Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsEnvironmental emergencies

ICU · Environmental emergencies

High-Altitude Illness

Also known as Acute mountain sickness · AMS · High-altitude cerebral edema · HACE · High-altitude pulmonary edema · HAPE · Acetazolamide

The high-altitude illness — the hypobaric hypoxia from the ascent. The spectrum: the AMS (the headache + the nausea / the fatigue / the dizziness), the HACE (the ataxia + the altered mental state — the brain oedema), the HAPE (the non-cardiogenic the pulmonary oedema). The DESCENT (the primary), the acetazolamide, the dexamethasone (the HACE), the nifedipine + the oxygen (the HAPE), the Gamow bag.

low47 referencesUpdated 2 Sept 202626 min readSource-verified · Sept 2026

Checked against its sources on 2 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC
The one-line answer

High-altitude illness is one injury — hypobaric hypoxia — wearing three faces and solved by one treatment — descent. The spectrum runs from AMS (headache plus at least one other symptom — nausea or vomiting, fatigue, dizziness; 2018 Lake Louise score at least 3, with sleep no longer a scored item), through HACE (ataxia with progressive alteration in mental status — regarded as the terminal, most severe form of AMS), to HAPE (non-cardiogenic pulmonary oedema after rapid ascent above 2500 m — exertional dyspnoea becoming dyspnoea at rest, cough, crackles, cyanosis). Descent is definitive: it is the single best treatment, and is mandatory, if at all possible, for the potentially fatal syndromes — with oxygen to maintain arterial saturation above 90%. The adjuncts match the syndrome: acetazolamide 125 mg every 12 hours for AMS prophylaxis (WMS 2019; 250 mg daily is the lowest dose in the 2012 Low meta-analysis), dexamethasone 8 mg once then 4 mg every 6 hours for HACE, and nifedipine extended-release 30 mg every 12 hours or 20 mg every 8 hours for HAPE.[10][2][43][6][36]

Meet the patient

A 34-year-old fit trekker is in the lodge at 4500 m on day 3. He flew to 2800 m two days ago and climbed fast. Overnight he became breathless at rest and coughed up pink frothy sputum; his tent-mate, who complained only of a headache yesterday, now cannot walk a straight line to the latrine. One has HAPE, the other has HACE — and the answer for both is the same word: descend.[1][3]

Hold that pairing: the breathless lungs and the stumbling brain are two faces of one process, and everything below unpacks why a single word — descent — decides who lives.[3]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References47ShowHide
  1. [1]Luks AM, et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update Wilderness Environ Med, 2024.PMID 37833187
  2. [2]Stream JO, Grissom CK Update on high-altitude pulmonary edema: pathogenesis, prevention, and treatment Wilderness Environ Med, 2008.PMID 19099331
  3. [3]Bärtsch P, et al. Prevention of high-altitude pulmonary edema by nifedipine N Engl J Med, 1991.PMID 1922223
  4. [4]Maggiorini M, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial Ann Intern Med, 2006.PMID 17015867
  5. [5]Sartori C, et al. Salmeterol for the prevention of high-altitude pulmonary edema N Engl J Med, 2002.PMID 12023995
  6. [6]Low EV, et al. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis BMJ, 2012.PMID 23081689
  7. [7]Gao D, et al. Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials Am J Med Sci, 2021.PMID 33587912
  8. [8]Hackett PH, Rennie D, Levine HD The incidence, importance, and prophylaxis of acute mountain sickness Lancet, 1976.PMID 62991
  9. [9]Honigman B, et al. Acute mountain sickness in a general tourist population at moderate altitudes Ann Intern Med, 1993.PMID 8452324
  10. [10]Roach RC, et al. The 2018 Lake Louise Acute Mountain Sickness Score High Alt Med Biol, 2018.PMID 29583031
  11. [11]Yuan F, et al. Echocardiographic Right Ventricular Outflow Track Notch Formation and the Incidence of Acute Mountain Sickness High Alt Med Biol, 2021.PMID 34152862
  12. [12]West JB, et al. Barometric pressures at extreme altitudes on Mt. Everest: physiological significance J Appl Physiol, 1983.PMID 6863078
  13. [13]Grocott MP, et al. Arterial blood gases and oxygen content in climbers on Mount Everest N Engl J Med, 2009.PMID 19129527
  14. [14]West JB, et al. Stress failure in pulmonary capillaries J Appl Physiol, 1991.PMID 2055852
  15. [15]Fischer R, et al. [Acute mountain sickness : How can it be treated and how can it be avoided?]. Internist (Berl), 2014.PMID 24522556
  16. [16]Joyce KE, et al. Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema Expert Opin Pharmacother, 2018.PMID 30307756
  17. [17]Jones BE, et al. Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m) Wilderness Environ Med, 2013.PMID 23062320
  18. [18]Walmsley M, et al. Continuous positive airway pressure as adjunct treatment of acute altitude illness High Alt Med Biol, 2013.PMID 24377348
  19. [19]Sikri G, et al. Is it time to revise the acclimatization schedule at high altitude? Evidence from a field trial in Western Himalayas Med J Armed Forces India, 2019.PMID 31388226
  20. [20]Burgess A, et al. Loop gain response to increased cerebral blood flow at high altitude Sleep Breath, 2024.PMID 38085496
  21. [21]Taylor AT High-altitude illnesses: physiology, risk factors, prevention, and treatment Rambam Maimonides Med J, 2011.PMID 23908794
  22. [22]Tenzing D, et al. Effect of furosemide in the treatment of high-altitude pulmonary edema BMC Pulm Med, 2024.PMID 38438895
  23. [23]von Olnhausen O, et al. Rapid Neurologic Deterioration in a Healthy Child at 4000 Meters: A Case Report and Literature Review of High Altitude Cerebral Edema in Children Wilderness Environ Med, 2026.PMID 41666204
  24. [24]Luks AM Evaluating the safety of high-altitude travel in patients with adult congenital heart disease Congenit Heart Dis, 2010.PMID 20576041
  25. [25]Lafleur J Cognitive effects of dexamethasone at high altitude Wilderness Environ Med, 2003.PMID 12659245
  26. [26]Basnyat B, Murdoch DR High-altitude illness Lancet, 2003.PMID 12801752
  27. [27]Tang E, et al. Dexamethasone for the prevention of acute mountain sickness: systematic review and meta-analysis Int J Cardiol, 2014.PMID 24679688
  28. [28]Furian M, et al. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients: Randomized Trial Chest, 2018.PMID 29909285
  29. [29]Duan C, et al. From lactate to lactylation: novel pathological mechanisms and potential therapeutic targets for high-altitude cerebral oedema Expert Rev Mol Med, 2026.PMID 41940507
  30. [30]Cai C, et al. Altitude hypoxia and hypoxemia: pathogenesis and management Signal Transduct Target Ther, 2026.PMID 41571626
  31. [31]Bay B [Mountain medicine. II]. Ugeskr Laeger, 2016.PMID 27808057
  32. [32]Maggiorini M [Prevention and therapy of altitude sickness]. Ther Umsch, 1993.PMID 8378872
  33. [33]McGowan J, et al. High Altitude Cerebral Edema StatPearls, 2026.PMID 28613666
  34. [34]Häfliger A, et al. Sex-Specific Difference in Health-Related Altitude-Effects and Their Prevention by Acetazolamide. Data from a Randomized Controlled Trial High Alt Med Biol, 2025.PMID 39778901
  35. [35]Berger MM, et al. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m J Appl Physiol, 2022.PMID 35511718
  36. [36]Burtscher J, et al. Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review Mil Med Res, 2025.PMID 40790769
  37. [37]Paudyal A, et al. High-altitude pulmonary edema: a case series of four patients from Nepal Ann Med Surg (Lond), 2026.PMID 42254115
  38. [38]Gehner J Altitude-Related Illness Emerg Med Clin North Am, 2024.PMID 38925772
  39. [39]Berghold F [Diagnosis and therapy of acute altitude sickness]. Wien Med Wochenschr, 2000.PMID 10960957
  40. [40]Grossman E, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA, 1996.PMID 8861992
  41. [41]Tan L, et al. Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial BMJ Open, 2022.PMID 35256446
  42. [42]Winter C, et al. Acute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure Front Physiol, 2021.PMID 34744786
  43. [43]Luks AM, Auerbach PS, Freer L, Grissom CK, Keyes LE, McIntosh SE, et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update Wilderness Environ Med, 2019.PMID 31248818
  44. [44]Hackett PH, Roach RC High-altitude illness N Engl J Med, 2001.PMID 11450659
  45. [45]Imray C, Booth A, Wright A, Bradwell A Acute altitude illnesses BMJ, 2011.PMID 21844157
  46. [46]Luks AM, Hackett PH Medical Conditions and High-Altitude Travel N Engl J Med, 2022.PMID 35081281
  47. [47]Bärtsch P, Swenson ER Clinical practice: Acute high-altitude illnesses N Engl J Med, 2013.PMID 23758234

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHeat Stroke & Heat IllnessEnvironmental emergenciesNextRadiation InjuryEnvironmental emergencies